{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T05:34:33Z","timestamp":1767850473875,"version":"3.49.0"},"reference-count":51,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2014,9,25]],"date-time":"2014-09-25T00:00:00Z","timestamp":1411603200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0108383","type":"journal-article","created":{"date-parts":[[2014,9,25]],"date-time":"2014-09-25T19:39:59Z","timestamp":1411673999000},"page":"e108383","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":25,"title":["Improving Mycobacterium bovis Bacillus Calmette-Gu\u00e8rin as a Vaccine Delivery Vector for Viral Antigens by Incorporation of Glycolipid Activators of NKT Cells"],"prefix":"10.1371","volume":"9","author":[{"given":"Manjunatha M.","family":"Venkataswamy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tony W.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shalu S.","family":"Kharkwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leandro J.","family":"Carre\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison J.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shajo","family":"Kunnath-Velayudhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Bittman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter J.","family":"Jervis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liam R.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gurdyal S.","family":"Besra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangshu","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiming","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moriya","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangming","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David D.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunhee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Frothingham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barton F.","family":"Haynes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael W.","family":"Panas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoffrey O.","family":"Gillard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaimie D.","family":"Sixsmith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birgit","family":"Korioth-Schmitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joern E.","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle H.","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William R.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven A.","family":"Porcelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,9,25]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"282","DOI":"10.2174\/157016210791208686","article-title":"Recombinant Mycobacterium bovis BCG as an HIV vaccine vector","volume":"8","author":"R Chapman","year":"2010","journal-title":"Curr HIV Res"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"6495","DOI":"10.1016\/j.vaccine.2009.08.044","article-title":"Recombinant Mycobacterium bovis BCG","volume":"27","author":"RG Bastos","year":"2009","journal-title":"Vaccine"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/351479a0","article-title":"Humoral and cell-mediated immune responses to live recombinant BCG-HIV vaccines","volume":"351","author":"A Aldovini","year":"1991","journal-title":"Nature"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0264-410X(94)90054-X","article-title":"Cytotoxic T lymphocyte response in mice induced by a recombinant BCG vaccination which produces an extracellular alpha antigen that fused with the human immunodeficiency virus type 1 envelope immunodominant domain in the V3 loop","volume":"12","author":"M Kameoka","year":"1994","journal-title":"Vaccine"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1089\/aid.1998.14.1625","article-title":"A cocktail of Mycobacterium bovis BCG recombinants expressing the SIV Nef, Env, and Gag antigens induces antibody and cytotoxic responses in mice vaccinated by different mucosal routes","volume":"14","author":"M Lagranderie","year":"1998","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/0264-410X(94)00001-4","article-title":"Recombinant BCG strains expressing the SIVmac251nef gene induce proliferative and CTL responses against nef synthetic peptides in mice","volume":"13","author":"N Winter","year":"1995","journal-title":"Vaccine"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.4049\/jimmunol.150.7.3101","article-title":"Immunization with recombinant BCG-SIV elicits SIV-specific cytotoxic T lymphocytes in rhesus monkeys","volume":"150","author":"Y Yasutomi","year":"1993","journal-title":"J Immunol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"12871","DOI":"10.1128\/JVI.79.20.12871-12879.2005","article-title":"Priming-boosting vaccination with recombinant Mycobacterium bovis bacillus Calmette-Guerin and a nonreplicating vaccinia virus recombinant leads to long-lasting and effective immunity","volume":"79","author":"Y Ami","year":"2005","journal-title":"J Virol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.1128\/JVI.02544-08","article-title":"Recombinant Mycobacterium bovis BCG prime-recombinant adenovirus boost vaccination in rhesus monkeys elicits robust polyfunctional simian immunodeficiency virus-specific T-cell responses","volume":"83","author":"MJ Cayabyab","year":"2009","journal-title":"J Virol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1002\/eji.201141962","article-title":"Optimizing HIV-1-specific CD8+ T-cell induction by recombinant BCG in prime-boost regimens with heterologous viral vectors","volume":"41","author":"R Hopkins","year":"2011","journal-title":"Eur J Immunol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1002\/eji.201040344","article-title":"Long peptides induce polyfunctional T cells against conserved regions of HIV-1 with superior breadth to single-gene vaccines in macaques","volume":"40","author":"M Rosario","year":"2010","journal-title":"Eur J Immunol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.vaccine.2004.08.039","article-title":"Factors influencing the immune response to foreign antigen expressed in recombinant BCG vaccines","volume":"23","author":"M Dennehy","year":"2005","journal-title":"Vaccine"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1399-0039.2009.01301.x","article-title":"Evasion and subversion of antigen presentation by Mycobacterium tuberculosis","volume":"74","author":"A Baena","year":"2009","journal-title":"Tissue Antigens"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1172\/JCI24617","article-title":"Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guerin mutants that secrete listeriolysin","volume":"115","author":"L Grode","year":"2005","journal-title":"J Clin Invest"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"4412","DOI":"10.1016\/j.vaccine.2009.05.048","article-title":"Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis","volume":"27","author":"R Sun","year":"2009","journal-title":"Vaccine"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"e5531","DOI":"10.1371\/journal.pone.0005531","article-title":"Reducing the activity and secretion of microbial antioxidants enhances the immunogenicity of BCG","volume":"4","author":"S Sadagopal","year":"2009","journal-title":"PLoS One"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1146\/annurev.immunol.25.022106.141711","article-title":"The biology of NKT cells","volume":"25","author":"A Bendelac","year":"2007","journal-title":"Annual review of immunology"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.immuni.2009.03.022","article-title":"Kinetics and cellular site of glycolipid loading control the outcome of natural killer T cell activation","volume":"30","author":"JS Im","year":"2009","journal-title":"Immunity"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1038\/ni1002","article-title":"Mechanism of CD1d-restricted natural killer T cell activation during microbial infection","volume":"4","author":"M Brigl","year":"2003","journal-title":"Nature immunology"},{"key":"ref20","first-page":"215","article-title":"CD1-restricted T cells in host defense to infectious diseases","volume":"314","author":"SM Behar","year":"2007","journal-title":"Current topics in microbiology and immunology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"5140","DOI":"10.4049\/jimmunol.171.10.5140","article-title":"NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells","volume":"171","author":"IF Hermans","year":"2003","journal-title":"Journal of immunology"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.smim.2009.10.002","article-title":"Adjuvant activity mediated by iNKT cells","volume":"22","author":"S Fujii","year":"2010","journal-title":"Semin Immunol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1084\/jem.20030324","article-title":"Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein","volume":"198","author":"S Fujii","year":"2003","journal-title":"The Journal of experimental medicine"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.coi.2010.04.003","article-title":"Synthetic iNKT cell-agonists as vaccine adjuvants\u2013finding the balance","volume":"22","author":"V Cerundolo","year":"2010","journal-title":"Curr Opin Immunol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"3984","DOI":"10.1073\/pnas.0700191104","article-title":"Invariant NKT cells sustain specific B cell responses and memory","volume":"104","author":"G Galli","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.vaccine.2008.02.002","article-title":"Enhancement of HIV DNA vaccine immunogenicity by the NKT cell ligand, alpha-galactosylceramide","volume":"26","author":"Y Huang","year":"2008","journal-title":"Vaccine"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"13010","DOI":"10.1073\/pnas.1006662107","article-title":"Design of a potent CD1d-binding NKT cell ligand as a vaccine adjuvant","volume":"107","author":"X Li","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.4049\/jimmunol.0900858","article-title":"Incorporation of NKT cell-activating glycolipids enhances immunogenicity and vaccine efficacy of Mycobacterium bovis bacillus Calmette-Guerin","volume":"183","author":"MM Venkataswamy","year":"2009","journal-title":"J Immunol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.humimm.2013.12.004","article-title":"Natural killer T cell anergy, co-stimulatory molecules and immunotherapeutic interventions","volume":"75","author":"AK Singh","year":"2014","journal-title":"Hum Immunol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1365-2567.2008.02943.x","article-title":"Identification of C-glycoside analogues that display a potent biological activity against murine and human invariant natural killer T cells","volume":"127","author":"X Li","year":"2009","journal-title":"Immunology"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"e78407","DOI":"10.1371\/journal.pone.0078407","article-title":"A glycolipid adjuvant, 7DW8-5, enhances CD8+ T cell responses induced by an adenovirus-vectored malaria vaccine in non-human primates","volume":"8","author":"NN Padte","year":"2013","journal-title":"PLoS One"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"5198","DOI":"10.1021\/ja200070u","article-title":"A rapid fluorescence-based assay for classification of iNKT cell activating glycolipids","volume":"133","author":"P Arora","year":"2011","journal-title":"J Am Chem Soc"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.clim.2010.11.009","article-title":"Clinical development of a novel CD1d-binding NKT cell ligand as a vaccine adjuvant","volume":"140","author":"NN Padte","year":"2011","journal-title":"Clin Immunol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1073\/pnas.1300200110","article-title":"Human CD1d knock-in mouse model demonstrates potent antitumor potential of human CD1d-restricted invariant natural killer T cells","volume":"110","author":"X Wen","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.immuni.2013.12.004","article-title":"A single subset of dendritic cells controls the cytokine bias of natural killer T cell responses to diverse glycolipid antigens","volume":"40","author":"P Arora","year":"2014","journal-title":"Immunity"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/978-1-4614-6111-1_11","article-title":"CD1d and natural killer T cells in immunity to Mycobacterium tuberculosis","volume":"783","author":"P Arora","year":"2013","journal-title":"Adv Exp Med Biol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nm1520","article-title":"CD8+ T-cell responses to different HIV proteins have discordant associations with viral load","volume":"13","author":"P Kiepiela","year":"2007","journal-title":"Nat Med"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"9228","DOI":"10.1128\/JVI.79.14.9228-9235.2005","article-title":"CD8+ T-lymphocyte response to major immunodominant epitopes after vaginal exposure to simian immunodeficiency virus: too late and too little","volume":"79","author":"MR Reynolds","year":"2005","journal-title":"J Virol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"796","DOI":"10.2741\/3278","article-title":"Harnessing human CD1d restricted T cells for tumor immunity: progress and challenges","volume":"14","author":"MV Dhodapkar","year":"2009","journal-title":"Front Biosci (Landmark Ed)"},{"key":"ref40","first-page":"3702","article-title":"A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors","volume":"8","author":"G Giaccone","year":"2002","journal-title":"Clin Cancer Res"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1172\/JCI24762","article-title":"Glycolipid antigen induces long-term natural killer T cell anergy in mice","volume":"115","author":"VV Parekh","year":"2005","journal-title":"J Clin Invest"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2217\/imt.10.85","article-title":"Invariant NK T cells: potential for immunotherapeutic targeting with glycolipid antigens","volume":"3","author":"L Van Kaer","year":"2011","journal-title":"Immunotherapy"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.smim.2009.10.003","article-title":"Lipid and glycolipid antigens of CD1d-restricted natural killer T cells","volume":"22","author":"MM Venkataswamy","year":"2010","journal-title":"Semin Immunol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.4049\/jimmunol.0901021","article-title":"Invariant TCR rather than CD1d shapes the preferential activities of C-glycoside analogues against human versus murine invariant NKT cells","volume":"183","author":"X Li","year":"2009","journal-title":"J Immunol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1084\/jem.20031192","article-title":"Superior protection against malaria and melanoma metastases by a C-glycoside analogue of the natural killer T cell ligand alpha-Galactosylceramide","volume":"198","author":"J Schmieg","year":"2003","journal-title":"J Exp Med"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"17275","DOI":"10.1073\/pnas.1114255108","article-title":"Avidity of CD1d-ligand-receptor ternary complex contributes to T-helper 1 (Th1) polarization and anticancer efficacy","volume":"108","author":"TN Wu","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.4049\/jimmunol.1202861","article-title":"Comparative analysis of the magnitude, quality, phenotype, and protective capacity of simian immunodeficiency virus gag-specific CD8+ T cells following human-, simian-, and chimpanzee-derived recombinant adenoviral vector immunization","volume":"190","author":"KM Quinn","year":"2013","journal-title":"J Immunol"},{"key":"ref48","first-page":"4654","article-title":"Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D. J Virol","volume":"81","author":"P Abbink","year":"2007"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"4705","DOI":"10.4049\/jimmunol.1100794","article-title":"NKT TCR recognition of CD1d-alpha-C-galactosylceramide","volume":"187","author":"O Patel","year":"2011","journal-title":"J Immunol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1073\/pnas.0407488102","article-title":"Modulation of CD1d-restricted NKT cell responses by using N-acyl variants of alpha-galactosylceramides","volume":"102","author":"KO Yu","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0022-1759(98)00204-X","article-title":"An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow","volume":"223","author":"MB Lutz","year":"1999","journal-title":"J Immunol Methods"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0108383","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,16]],"date-time":"2023-07-16T19:57:39Z","timestamp":1689537459000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0108383"}},"subtitle":[],"editor":[{"given":"Johan K.","family":"Sandberg","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,9,25]]},"references-count":51,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2014,9,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0108383","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,25]]}}}